Picture of Granules India logo

GRANULES — Granules India News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Granules India quarterly profit jumps on strong demand in North America, Europe

Jan 23 (Reuters) - Paracetamol maker Granules India GRAN.NS reported a 28% jump in third-quarter profit on Friday, driven by strong demand in its key European and North American markets.

Consolidated profit rose to 1.5 billion rupees ($16.3 million) in the quarter ended December 31, from 1.18 billion rupees a year ago.

Granules posted a 22% rise in revenue from operations to 13.88 billion rupees.

North America, which generates about two-thirds of the firm's revenue, logged a 14% jump in sales. Europe sales, which contribute 19% to the topline, more than doubled.

For further earnings highlights, click nFWN3YO01W.

KEY CONTEXT

Granules India accounts for about 30% of the global paracetamol market and supplies the drug both as an active pharmaceutical ingredient (API) and in finished dosage form across Europe, Canada and South Africa.

APIs are key chemical components that give medicines their therapeutic effect.

Indian API makers are facing pricing pressure in major Western markets due to intensifying competition, even as global drugmakers increasingly look to India to diversify supply chains and cut reliance on Chinese suppliers.

PEER COMPARISON

Estimates (next 12 months)Analysts' sentiment
RICPEEV/EBITDARevenue growth (%)Profit growth (%)Mean rating*# of analystsStock to price target**Div yield (%)
Granules India LtdGRAN.NS21.1211.9215.3722.31Buy30.950.26
Laurus Labs LtdLAUL.NS63.9831.2316.4237.84Hold141.170.15
Alivus Life Sciences LtdALIV.NS17.6011.8412.3716.33Strong Buy40.730.57
Divi's Laboratories LtdDIVI.NS54.5338.7217.9922.38Hold280.920.48
* Mean of analysts' ratings standardised to a scale of Strong Buy, Buy, Hold, Sell, and Strong Sell ** Ratio of the stock's last close to analysts' mean price target; a ratio above 1 means the stock is trading above the PT OCTOBER TO DECEMBER STOCK PERFORMANCE -- All data from LSEG -- $1 = 91.8590 Indian rupees GRAN v Peers https://tmsnrt.rs/3Zp2AUm (Reporting by Kashish Tandon and Nandan Mandayam in Bengaluru; Editing by Sumana Nandy and Harikrishnan Nair) ((Kashish.Tandon@thomsonreuters.com; 8800437922;))

Recent news on Granules India

See all news